Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies.

MLA

Davies, Melanie, et al. “Insulin Glargine-Based Therapy Improves Glycemic Control in Patients with Type 2 Diabetes Sub-Optimally Controlled on Premixed Insulin Therapies.” Diabetes Research and Clinical Practice, vol. 79, no. 2, Feb. 2008, pp. 368–75. EBSCOhost, https://doi.org/10.1016/j.diabres.2007.09.013.

APA

Davies, M., Sinnassamy, P., Storms, F., & Gomis, R. (2008). Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies. Diabetes Research and Clinical Practice, 79(2), 368–375. https://doi.org/10.1016/j.diabres.2007.09.013

Chicago

Davies, Melanie, Patrick Sinnassamy, Fred Storms, and Ramon Gomis. 2008. “Insulin Glargine-Based Therapy Improves Glycemic Control in Patients with Type 2 Diabetes Sub-Optimally Controlled on Premixed Insulin Therapies.” Diabetes Research and Clinical Practice 79 (2): 368–75. doi:10.1016/j.diabres.2007.09.013.